コベルコ神戸スティーラーズ、NTTリーグワン2025-26season 優勝🏆🏅🥇
KOBELCO KOBE STEELERS win the NTT League One 2025-26 season championship! 🏆🏅🥇
#コベルコ神戸スティーラーズ#KOBELCOKOBESTEELERS
Presented at #EULAR2026:
In a phase 3 trial, obexelimab led to a lower risk of disease flares than placebo among patients with IgG4-related disease. Glucocorticoid use was lower and the incidence of remission was higher with obexelimab than with placebo. Full INDIGO trial results: https://t.co/Lynf6nmA9N
Editorial: Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease https://t.co/BUQ7r8jVWz
@eular_org
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26